Volume Growth Key for Hemostasis and Tissue Sealing Agents Market Likely to Touch US$5.2 Bn in 2020
Hemostasis and tissue sealing agents play a vital role in simplifying wound sealing procedures during surgeries. Primarily, the global hemostasis and tissue sealing agents market is driven by the introduction of new products. For example, in May 2014, the Sylys Surgical Sealant was introduced by Cohera Medical, Inc.; it can be used in gastrointestinal surgery. In January 2014, Baxter received the U.S. FDA approval for the TISSEEL fibrin sealant that is used for various surgeries. The constant introduction of new...
View full press release